ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1995

Cross-cultural Adaptation, Reduction, and Validation of the Turkish Versions of the Flare-OA Questionnaire for Hip and Knee Osteoarthritis

Mehmet Tuncay Duruöz1, Halise Hande Gezer1, Jonathan Epstein2, Marc Soudant2 and Francis Guillemin3, 1Marmara University Medical School PMR Department, Rheumatology Division, Istanbul, Turkey, 2Université de Lorraine, Epidémiologie clinique, Nancy, France, 3Université de Lorraine, EA 4360 Apemac, Nancy, France

Meeting: ACR Convergence 2023

Keywords: Measurement Instrument, OMERACT, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1977–1995) Osteoarthritis – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The Flare-OA is a recently developed self-reported questionnaire to assess the occurrence and severity of flares in knee and hip osteoarthritis (OA). It evaluates five aspects (pain, swelling, stiffness, consequences of symptoms, and psychological) of flare. This study aimed to translate and cross-culturally adapt the Flare-OA and its short forms using classical psychometric analysis methods in a Turkish population.

Methods: The French/English version of the questionnaire was cross-culturally adapted and translated into Turkish following an established forward–backward translation procedure. The Turkish version was checked by an expert committee for translation understandability, interpretation, and cultural relevance with ten patients (Face validity). Patients who were≥45 years of age with clinical and radiological OA of the knee or hip, according to ACR criteria were included. The Flare OA scale consists of 33 items and has been reduced to 19 items by factor analysis and content approach. Further work with the Rasch analysis allowed to refine and shorten the questionnaire to a 16-item version with a satisfactory interval scale. The reliability of Flare-OA was assessed by internal consistency (Cronbach’s alpha coefficient) and test-retest reliability at 15 days in patients without change. The sensitivity to change was assessed by standardized response mean (SRM) in those reporting change over the period. The convergent validity was assessed by the correlation of the Flare-OA with the Hip Disability and Osteoarthritis Outcome score (HOOS), Knee Injury and Osteoarthritis Outcome Score (KOOS), and the Mini Osteoarthritis Knee and Hip Quality of Life Questionnaire (Mini-OAKHQOL).

Results: A total of 185 (71.9% females) patients with a mean age of 63.2 (SD:9.1) years participated. One hundred-sixty (86.5%) of the patients had knee OA, 25(13.5%) had hip OA, and 70 (37.8%) had experienced worsening of the knee or hip OA during the last four weeks. The confirmatory factor analysis found the model with 19 items acceptable (RMSEA=0.08; SRMR=0.05; and CFI=0.95). Cronbach’s alpha coefficient was 0.987 (95% CI:0.984-0.990) for 33-item, 0.978 (95% CI:0.973-0.982) for 19-item, and 0.972 (95% CI:0.966-0.978) for 16-item. The intraclass correlation coefficient was 0.913 (95% CI:0.868-0.943), 0.915 (95% CI:0.870-0.944), and 0.912 (95% CI:0.866-0.943) in 79 patients for the test–retest reliability of the 33, 19, and 16 items, respectively. Sensitivity to change (n=89) was good in 9 patients with flare improvement [SRM 1.2 (95% CI:0.6–1.7), 1 (95% CI:0.5–1.4, and 1 (95% CI:0.5–1.5); 33, 19, and 16 items, respectively] over the period. The discriminant validity was evidenced by a significant score difference [36.2 (95% CI:29.9-42.6), 36.6 (95% CI:30.2-43.0), and 36.7 (95% CI:30.3-43.0)]for 33, 19, and 16 items, respectively between patients with and without flare. Pearson’s correlation coefficients of the questionnaire with the other parameters for construct validity are represented in Table.

Conclusion: This study demonstrated that all the 33, 19, and 16-items Turkish versions of the Flare OA questionnaire are reliable and valid tools for assessing flaring in patients with knee and hip OA.

Supporting image 1

Table. Pearson’s correlation coefficients of the Flare-OA questionnaire with the other parameters for construct validity


Disclosures: M. Duruöz: None; H. Gezer: None; J. Epstein: None; M. Soudant: None; F. Guillemin: None.

To cite this abstract in AMA style:

Duruöz M, Gezer H, Epstein J, Soudant M, Guillemin F. Cross-cultural Adaptation, Reduction, and Validation of the Turkish Versions of the Flare-OA Questionnaire for Hip and Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/cross-cultural-adaptation-reduction-and-validation-of-the-turkish-versions-of-the-flare-oa-questionnaire-for-hip-and-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cross-cultural-adaptation-reduction-and-validation-of-the-turkish-versions-of-the-flare-oa-questionnaire-for-hip-and-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology